Intervention: INO-1400 or INO-1401 Plasmid encoding hTERT variants, with or with-out plasmid encoding IL-12Key results: Survival of patients with pancreatic cancer, tolerance, enhanced CD8+ response. This evidence concerns the gene CD8A and pancreatic neoplasm.